- Home
- CTNM vs EGY Comparison
CTNM vs EGY Comparison
Compare CTNM & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CTNM | EGY |
|---|---|---|
| Founded | 2009 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.0M | 577.6M |
| IPO Year | 2024 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CTNM | EGY |
|---|---|---|
| Price | $13.49 | $6.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.00 | $7.30 |
| AVG Volume (30 Days) | 322.2K | ★ 1.6M |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | ★ 0.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $359,272,000.00 |
| Revenue This Year | N/A | $17.04 |
| Revenue Next Year | N/A | $20.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $3.00 |
| 52 Week High | $16.33 | $6.45 |
Technical Indicators
Market Signals| Indicator | CTNM | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 69.43 |
| Support Level | $10.39 | $3.51 |
| Resistance Level | $15.80 | N/A |
| Average True Range (ATR) | 1.11 | 0.27 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 44.00 | 77.98 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.